Corrigendum: Metabonomic analysis of the anti-hepatic fibrosis effect of Ganlong capsules

Front Pharmacol. 2023 Jul 7:14:1231544. doi: 10.3389/fphar.2023.1231544. eCollection 2023.

Authors

ChangLing Lv^{1

2}, YinRui Li³, Ling Ou^{1

2}, Jie Zhou^{1

2}, Fang Peng^{1

2}, DingYu Wu^{1

2}

Affiliations

¹ College of Pharmacy, Dali University, Dali, China.
² Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, Dali, China.
³ Department of Pharmacy, Mengzi People's Hospital, Mengzi, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2023.1122118.].

Keywords: CCl4; Ganlong capsule; LC-MS; hepatic fibrosis; metabolomic analysis.

Copyright © 2023 Lv, Li, Ou, Zhou, Peng and Wu.

Publication types

Published Erratum